These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Clinical experiences with an antiarrhythmic drug combination]. Klinnert U Med Welt; 1972 Dec; 23(49):1878-80. PubMed ID: 4566977 [No Abstract] [Full Text] [Related]
23. [Comparative characteristics of the antiarrhythmic activity of lidocaine, trimecaine and pyromecaine]. Orlov VM; Ivashchuk AG; Iartsev SS; Meshcheriakova NK; Tkhu FT Sov Med; 1984; (3):82-4. PubMed ID: 6719244 [No Abstract] [Full Text] [Related]
26. [Current anti-arrhythmic treatments and drugs]. Chiche P; Witchitz S; Naouri L; Philippe B Coeur Med Interne; 1973; 12(1):129-44. PubMed ID: 4146955 [No Abstract] [Full Text] [Related]
27. Papaverine as an antiarrhythmic agent. Whipple GH Angiology; 1977 Nov; 28(11):737-49. PubMed ID: 333993 [No Abstract] [Full Text] [Related]
28. [The effect of anti-arrhythmia agents on ventricular arrhythmias arising as a consequence of disorders in the myocardial blood supply]. Gendenshteĭn EI; Kostin IaV; Markelova NN; Balashov VP; Oleĭnikov VE; Perevarin AV Farmakol Toksikol; 1990; 53(4):28-30. PubMed ID: 2226754 [TBL] [Abstract][Full Text] [Related]
29. [Antiarrhythmic action of certain 1,5-diphenyl-bispidin derivatives]. Cartoni C; Figini A; Carpi A Ann Ist Super Sanita; 1968; 4(3):333-5. PubMed ID: 5734619 [No Abstract] [Full Text] [Related]
30. Observations on models used for the evaluation of antiarrhythmic drugs. Baum T; Eckfeld DK; Shropshire AT; Rowles G; Varner LL Arch Int Pharmacodyn Ther; 1971 Sep; 193(1):149-70. PubMed ID: 5111320 [No Abstract] [Full Text] [Related]
31. [Antiarrhythmic, cardiovascular and toxic actions of N,N'-bis-[3-(2'-ethoxyphenoxy)-2-hydroxypropyl]-ethlenediamine (Falirytmin) as compared to propranolol, quinidine and ajmaline]. Terhaag B; Förster W Pharmazie; 1976; 31(9):635-9. PubMed ID: 1019213 [No Abstract] [Full Text] [Related]
32. [Characteristics of pharmacological and toxic effects of verapamil during cardiac arrhythmia in thyrotoxic and hypothyroid rats]. Sokhanenkova AE; Sokhanenkov MIu; Afanas'eva EIu; Arzamastsev EV Kardiologiia; 2008; 48(6):57-61. PubMed ID: 18729838 [TBL] [Abstract][Full Text] [Related]
34. [Effectiveness of obsidan, isoptin, procaine amide and quinidine in the treatment of various types of arrhythmia]. Chizh VD Vrach Delo; 1977 Oct; (10):64-6. PubMed ID: 602135 [No Abstract] [Full Text] [Related]
35. [Effectiveness of trimecaine, a new anti-arrhythmia agent]. Gendenshteĭn EI; Ganelina IE; Kostin IaV; Kukuĭ LM; Tsybusov AP Klin Med (Mosk); 1980 Jun; 58(6):47-50. PubMed ID: 7401603 [No Abstract] [Full Text] [Related]
36. [Various aspects of the anti-arrhythmia action of trimecaine and its effect on hemodynamics]. Kostin IaV; Oleĭnikov VE; Sernov LN; Tatarchenko IP; Gendenshteĭn EI Farmakol Toksikol; 1984; 47(1):47-50. PubMed ID: 6200357 [No Abstract] [Full Text] [Related]
37. [The effect of a combination of N-propylajmaline bromide and trimecaine on heart arrhythmias of different origins and on the electrophysiological parameters of the myocardium]. Gendenshteĭn EI; Balashov VP; Sosunov EA; Kostin IaV; Oleĭnikov VE Farmakol Toksikol; 1991; 54(4):30-3. PubMed ID: 1786818 [TBL] [Abstract][Full Text] [Related]
38. Studies on a new 1,5-benzothiazepine derivative (CRD-401). V. Antiarrhythmic actions. Yamada K; Shimamura T; Nakajima H Jpn J Pharmacol; 1973 Jun; 23(3):321-8. PubMed ID: 4146776 [No Abstract] [Full Text] [Related]
39. [Role of surface phenomena in the mechanism of action of antiarrhythmic substances]. Prianishnikova NT; Samvelian VM; Diadiura ZhA Biull Eksp Biol Med; 1976 Dec; 82(12):1451-3. PubMed ID: 1023973 [TBL] [Abstract][Full Text] [Related]
40. A cardiac antiarrhythmic screening test in the rat: the effects of lidocaine, propranolol and quinidine. Baker T; Erker EF Arch Int Pharmacodyn Ther; 1980 Jan; 243(1):97-102. PubMed ID: 7387264 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]